Yong‐Ping Chen

机构：Hohai University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Suzhou University of Science and Technology, Fujian Academy of Agricultural Sciences, Fruit Research Institute, Yangzhou University · ORCID：0000-0001-9615-5709

发表论文 95 篇 · 总被引 2441 次 · h-index 27

代表论文

• C C chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice (2021 · Metabolism · 被引 88)
• Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B (2022 · Journal of Hepatology · 被引 72)
• Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial (2021 · Hepatology · 被引 35)
• A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative (2024 · Hepatology · 被引 27)
• An ultrasound image‐based deep multi‐scale texture network for liver fibrosis grading in patients with chronic HBV infection (2021 · Liver International · 被引 22)
• ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs (2022 · Journal of Hepatology · 被引 20)